Keyphrases
Early Breast Cancer
100%
Node-negative
100%
Autoantibodies
100%
Breast Cancer
50%
Tumor Antigen
50%
Receptor for Activated C Kinase 1 (RACK1)
50%
Galectin-3 (Gal-3)
50%
Validation Set
25%
Enzyme-linked Immunosorbent Assay (ELISA)
25%
In Cancer
25%
Diagnostic Tool
25%
Screening Strategy
25%
Cancer Patients
25%
Healthy Individuals
25%
Proteomic Approach
25%
Ductal Carcinoma in Situ
25%
Early Cancer
25%
Humoral Response
25%
Mammography
25%
Newly Diagnosed Patients
25%
Patient Serum
25%
Primary Breast Cancer
25%
Breast Density
25%
Clinical Validation
25%
Pre-invasive
25%
PAK2
25%
Circulating Autoantibodies
25%
Serological Screening
25%
PHB2
25%
RUVBL1
25%
Biochemistry, Genetics and Molecular Biology
Autoantibodies
100%
Tumor Antigen
40%
Enzyme
20%
Proteomics
20%
Humoral Immunity
20%
Cancer Staging
20%
Breast Density
20%
PAK2
20%
Immunology and Microbiology
Autoantibodies
100%
Tumor Antigen
40%
Enzyme-Linked Immunosorbent Assay
20%
Humoral Immunity
20%
Cancer Staging
20%